Gender-specific symptom outcomes on cariprazine treatment: a 12-month naturalistic longitudinal follow-up study in schizophrenia - Quiz - MDSpire

Gender-specific symptom outcomes on cariprazine treatment: a 12-month naturalistic longitudinal follow-up study in schizophrenia

  • By

  • Claudia Carmassi

  • Virginia Pedrinelli

  • Andrea Bordacchini

  • Berenice Rimoldi

  • Livia Parrini

  • Carlo A. Bertelloni

  • Valerio Dell’Oste

  • June 23, 2026

  • 0 min

Share

Original Source(s)

Gender-specific symptom outcomes on cariprazine treatment: a 12-month naturalistic longitudinal follow-up study in schizophrenia

  • by Claudia Carmassi, Virginia Pedrinelli, Andrea Bordacchini, Berenice Rimoldi, Livia Parrini, Carlo A. Bertelloni, Valerio Dell’Oste

  • June 23, 2026

Related Content

Associations between serum tumor necrosis factor-alpha, hippocampal-prefrontal-ventricular volumes, and clinical profiles in schizophrenia: a biomarker and neuroimaging study in North Sumatera, Indonesia

Developmental high-risk criteria for severe mental illness: a neurodevelopmental framework for premorbid detection

The many manifestations of magical thinking: a systematic review